These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1428569)

  • 1. The effects of dopamine, haloperidol and bromocriptine on intraocular pressure.
    Elibol O; Güler C; Yüksel N
    Int Ophthalmol; 1992 Sep; 16(4-5):343-7. PubMed ID: 1428569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The determination of additive effect and intraocular pressure lowering effects of 0.05% bromocriptine and 0.25% timolol.
    Elibol O; Güler C; Arici K; Topalkara A; Demircan S
    Int Ophthalmol; 1996-1997; 20(1-3):53-5. PubMed ID: 9112164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of dopamine receptors (type 2) lowers human intraocular pressure.
    Mekki QA; Turner P
    Br J Ophthalmol; 1985 Dec; 69(12):909-10. PubMed ID: 4084483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopamine agonist, bromocriptine, and some dopamine antagonists on ocular blood flow.
    Chiou GC; Chen YJ
    J Ocul Pharmacol; 1992; 8(4):285-94. PubMed ID: 1484260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel dopamine D-1 antagonist and D-2 agonist, SDZ GLC-756, lowers intraocular pressure in healthy human volunteers and in patients with glaucoma.
    Prünte C; Flammer J
    Ophthalmology; 1995 Sep; 102(9):1291-7. PubMed ID: 9097765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dopamine on the intraocular pressure and pupil of the rabbit eye.
    Shannon RP; Mead A; Sears ML
    Invest Ophthalmol; 1976 May; 15(5):371-80. PubMed ID: 1262169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the ocular hypotensive effect of 0.025% bromocriptine and 0.25% timolol eye drops in normal human volunteers.
    al-Sereiti MR; Coakes RL; O'Sullivan DP; Turner P
    Br J Clin Pharmacol; 1989 Oct; 28(4):443-7. PubMed ID: 2590602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine lowers intraocular pressure without affecting blood pressure.
    Mekki QA; Hassan SM; Turner P
    Lancet; 1983 Jun; 1(8336):1250-1. PubMed ID: 6134042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is topical haloperidol a useful glaucoma treatment?
    Lavin MJ; Andrews V
    Br J Ophthalmol; 1986 Jun; 70(6):448-50. PubMed ID: 3718908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine eyedrops lower intraocular pressure without affecting prolactin levels.
    Mekki QA; Warrington SJ; Turner P
    Lancet; 1984 Feb; 1(8371):287-8. PubMed ID: 6143030
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral haloperidol lowers human intraocular pressure.
    Sheppard JD; Schaid DJ
    J Ocul Pharmacol; 1986; 2(3):215-24. PubMed ID: 3503108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of timolol maleate gel-forming solution on intraocular pressure, pupil diameter, and heart rate in normal and glaucomatous cats.
    Kiland JA; Voss AM; McLellan GJ
    Vet Ophthalmol; 2016 Jul; 19 Suppl 1(Suppl 1):91-6. PubMed ID: 26991029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clozapine and haloperidol on some autonomic and psychomotor functions, and on serum prolactin concentration, in healthy subjects.
    Pretorius JL; Phillips M; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 2001 Sep; 52(3):322-6. PubMed ID: 11560566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of local application of 1% dopamine on intraocular pressure and pupillary diameter.
    Aleksić P; Durović B; Raicević R
    Vojnosanit Pregl; 1999; 56(5):471-5. PubMed ID: 10645150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man.
    Abduljawad KA; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 1998; 12(3):239-45. PubMed ID: 10958249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotensive effect of bromocriptine in glaucomatous eyes.
    Geyer O; Robinson D; Lazar M
    J Ocul Pharmacol; 1987; 3(4):291-4. PubMed ID: 3503918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topical ketanserin administration on intraocular pressure.
    Costagliola C; Iuliano G; Rinaldi M; Russo V; Scibelli G; Mastropasqua L
    Br J Ophthalmol; 1993 Jun; 77(6):344-8. PubMed ID: 8318480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of lisuride, terguride and bromocriptine on intraocular pressure (IOP).
    Al-Sereiti MR; Turner P
    Br J Clin Pharmacol; 1989 Feb; 27(2):159-63. PubMed ID: 2713211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.
    Schuman JS
    Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brimonidine tartrate: a one-month dose response study.
    Derick RJ; Robin AL; Walters TR; Barnebey HS; Choplin N; Schuman J; Kelley EP; Chen K; Stoecker JF
    Ophthalmology; 1997 Jan; 104(1):131-6. PubMed ID: 9022117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.